Ascorbic acid Completed Phase 2 Trials for Sepsis / Acute Lung Injury (ALI) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02106975Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury
NCT02734147High Dose Intravenous Ascorbic Acid in Severe Sepsis